{
  "retracted": false,
  "timestamp": 1527811200000,
  "updates": [
    {
      "timestamp": 1574817149658,
      "identifier": {
        "doi": "10.1016/j.phrs.2018.03.007"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.phrs.2017.08.010"
  },
  "journal": "Pharmacological Research",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Targeting NAD+ degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty” [Pharmacol. Res. 128 (February) (2018) 345–358]"
}
